期刊文献+

临床分离阴沟肠杆菌中新型氨基糖苷类乙酰转移酶基因的检测 被引量:2

Detection of the new type of aminoglycoside acetyltransferase gene in Enterobacter cloacae isolates
原文传递
导出
摘要 目的了解临床分离阴沟肠杆菌中新型氨基糖苷类乙酰转移酶基因[aac(6’)---Ib-cr基因]的分布。方法PCR检测aac(6’)-Ib-cr基因并将阳性扩增产物进行测序分析;纸片扩散法测定aac(6’)-Ib-cr基因阳性菌株对13种抗菌药物的敏感性;改良三维试验检测高产AmpC酶和ESBLs;ERIC-PCR法进行aac(6’)-Ib-cr基因阳性菌株同源性检测。结果81株阴沟肠杆菌中,3株aac(6’)-Ib-cr基因阳性(3.7%);aac(6’)-Ib-cr基因阳性菌株对氟喹诺酮类,氨基糖苷类,氯霉素,氨苄西林,头孢西丁,第2、3代头孢菌素等显示多重耐药2株产ESBLs和AmpC,1株产ESBLs;ERIC-PCR电泳图谱型显示,3株aac(6’)-Ib.cr基因阳性细菌均不属于同一型别。结论临床分离阴沟肠杆菌中存在aac(6’)-Ib-cr基因阳性菌株,为多重耐药、非克隆传播菌株,临床应加强检测和监测。 Objective To investigate the prevalence of aac(6')-Ib-cr gene in Enterobacter cloacae isolates. Methods PCR and sequencing were performed on 81 strains of Enterobacter cloacae isolated clinically in Anhui province to identify aac (6')-IB-cr gene. Disk diffusion method was used to test the susceptibility of the Enterobacter cloacae isolates with aac (6')-Ib-cr gene to fluoroquinolones, aminoglycosides, and other antimicrobial agents. AmpC and extended-spectrum β-lactamases (ESBLs) were detected by modified three-dimensional extract test, and the molecular typing was analyzed by ERIC-PCR. Results aac (6')-Ib-cr gene was identified in 3 (3.7 % ) of the 81 Enterobacter cloacae isolates with different ERIC-PCR patterns. The isolates with aac (6')-Ib-cr gene were resistant to fluoroquinolones, aminoglycosides, chloramphenicol, ampicillin, cefoxitin, and second and third generation cephalosporins. Two of the 3 isolates produced AmpC and ESBLs, and 1 isolate produced only ESBLs. Conclusion aac (6')-Ib-cr gene is prevalent in Enterobacter cloacae isolates with resistance to most of antimicrobial agents and no clone spread in found in them.
出处 《中华医学杂志》 CAS CSCD 北大核心 2008年第6期422-424,共3页 National Medical Journal of China
基金 中国博士后科学基金资助项目(20060400202) 安徽省自然科学基金资助项目(050430804) 安徽省高等学校省级自然科学研究基金资助项目(KJ2007B145)
关键词 肠杆菌 阴沟 氨基糖苷类 抗药性 Enterobacter cloacae Aminoglycosides Drug resistance
  • 相关文献

参考文献11

  • 1顾怡明,张杰,俞云松,周志慧,杜小玲.多重耐药阴沟肠杆菌流行状况及耐药机制的研究[J].中华医院感染学杂志,2004,14(12):1321-1324. 被引量:62
  • 2熊自忠,李涛,李慧,周强.产超广谱β-内酰胺酶大肠埃希菌对喹诺酮类抗菌药物的耐药性检测[J].中国微生态学杂志,2005,17(6):452-453. 被引量:13
  • 3Hooper DC. Mechanisms of fluroquinolone resistance. Drug Resistance Updates, 1999, 2: 38-55.
  • 4Martinez-Martinez L, Pascual LA, Jacopy GA. Quinolone resistant from a transferable plasmid. Lancet, 1998, 351: 797-799.
  • 5Jaeoby GA, Chow N, Waites KB. Prevalence of plasmid-mediated quinolone resistance. Antimicrob Agents Chemother, 2003, 47: 559-562.
  • 6Wang M, Tran JH, Jacoby GA, et al. Plasmid-mediated quinolone resistance in clinical of Eschefichia coli from Shanghai, China. Antimicrob Agents Chemother, 2003, 47 : 2242-2248.
  • 7Wang M, Sahm DF, Jacoby GA, et al. Emerging plasmid- mediated quinolone resistance associated with qnr gene in Klebsiella pneumoniae clinical isolates in the United States. Antimicrob Agents Chemother, 2004, 48: 1295-1299.
  • 8Robicsek A, Strahilevitz J, Jacoby GA, et al. Fluoroquinolone- modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase. Nat Med,2006,12 : 83-88.
  • 9Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. M100-S16,2006.
  • 10Shahid M, Malik A, Agrawal M, et al. Phenotypic detection of extended-spectrum and AmpC beta-lactamases by a new spotinoculation method and modified three-dimensional extract test: comparison with the conventional three-dimensional extract test. J Antimicrob Chemother, 2004, 54: 684-687.

二级参考文献40

  • 1[2]Coudron PE, Moland ES, Thomson KS. Occurrence and detection of AmpC beta-lactamases among Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis isolates at a veterans medical center[J]. J Clin Microbiol, 2000, 38(5): 1791-1796.
  • 2[3]Mathew A, Harris AM, Marshall MJ, et al. The use of analytical isoelectric focusing for detection and identification of beta-lactamases[J]. J Gen Microbiol, 1975, 88(1): 169-178.
  • 3[4]Kopp U, Wiedemann B, Lindquist S, et al. Sequences of wild-type and mutant ampD genes of Citrobacter freundii and Enterobacter cloacae[J]. Antimicrob Agents Chemother, 1993, 37(2): 224-228.
  • 4[5]Hennessey TD. Inducible beta-lactamase in Enterobacter cloacae[J]. J Gen Microbiol, 1967, 49(2): 277-285.
  • 5[6]Quinteros M, Radice M, Gardella N, et al. Extended-spectrum beta-lactamases in Enterobacteriaceae in Buenos Aires, Argentina, public hospitals[J]. Antimicrob Agents Chemother, 2003, 47(9): 2864-2867.
  • 6[7]Morris D, O′Hare C, Glennon M, et al. Extended-spectrum beta-lactamases in Ireland, including a novel enzyme, TEM-102[J]. Antimicrob Agents Chemother, 2003, 47(8): 2572-2578.
  • 7[8]Levison ME, Mailapur YV, Pradhan SK, et al. Regional occurrence of plasmid-mediated SHV-7, an extended-spectrum beta-lactamase, in Enterobacter cloacae in Philadelphia teaching hospitals[J]. Clin Infect Dis, 2002, 35(12): 1551-1554.
  • 8[10]Ehrhardt AF, Sanders CC, Romero JR, et al. Sequencing and analysis of four new Enterobacter ampD alleles[J]. Antimicrob Agents Chemother, 1996, 40(3): 1953-1956.
  • 9Bonnet R. Growing group of extended-spectrum β-lactamases: the CTX-M enzymes[J]. Antimicrob Agents Chemother, 2004, 48: 1-14.
  • 10Zizhong Xiong, Demei Zhu, Fu Wang,et al.Investigation of extended-spectrum β-lactamase in Klebsiellae pneumoniae and Escherichia coli from China[J]. Diag Microbiol Infect Dis,2002, 44 (2): 195-200.

共引文献87

同被引文献18

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部